DNA Gyrase Inhibitors Increase the Frequency of Bacteriophage-like RcGTA-Mediated Gene Transfer in Rhodobacter capsulatus

Genes (Basel). 2022 Nov 9;13(11):2071. doi: 10.3390/genes13112071.

Abstract

Rhodobacter capsulatus produces a bacteriophage-like particle called the gene transfer agent (RcGTA) that mediates horizontal gene transfer. RcGTA particles transfer random ~4.5-kb fragments of genomic DNA that integrate into recipient genomes by allelic replacement. This work addresses the effect of sub-inhibitory concentrations of antibiotics on gene transfer by RcGTA. A transduction assay was developed to test the effects of various substances on gene transfer. Using this assay, low concentrations of DNA gyrase inhibitors were found to increase the frequency of gene transfer. Novobiocin was studied in more detail, and it was found that this antibiotic did not influence the production or release of RcGTA but instead appeared to act on the recipient cells. The target of novobiocin in other species has been shown to be the GyrB subunit of DNA gyrase (a heterotetramer of 2GyrA and 2GyrB). R. capsulatus encodes GyrA and GyrB homologues, and a GyrB overexpression plasmid was created and found to confer resistance to novobiocin. The presence of the overexpression plasmid in recipient cells greatly diminished the novobiocin-mediated increase in gene transfer, confirming that this effect is due to the binding of novobiocin by GyrB. The results of this work show that antibiotics affect gene transfer in R. capsulatus and may be relevant to microbial genetic exchange in natural ecosystems.

Keywords: DNA gyrase; RcGTA; Rhodobacter; antibiotic; ciprofloxacin; gene transfer agent; horizontal gene transfer; novobiocin; phage; subinhibitory concentration; virus.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / pharmacology
  • Bacterial Proteins / metabolism
  • Bacteriophages*
  • Ecosystem
  • Gene Expression Regulation, Bacterial
  • Novobiocin / metabolism
  • Novobiocin / pharmacology
  • Rhodobacter capsulatus* / genetics
  • Rhodobacter capsulatus* / metabolism
  • Topoisomerase II Inhibitors / pharmacology

Substances

  • Topoisomerase II Inhibitors
  • Novobiocin
  • Bacterial Proteins
  • Anti-Bacterial Agents

Grants and funding

This research was funded by a grant from the Canadian Natural Sciences and Engineering Research Council (NSERC) to J.T.B. (grant number RGPIN 2018-03898).